Literature DB >> 7692148

Hypertension as a risk factor for cardiac events--epidemiologic results of long-term studies.

W B Kannel1.   

Abstract

Hypertension is a major contributor to cardiovascular disease, which imparts a threefold increased risk over that of normotensive persons the same age. It accelerates atherogenesis-promoting premature coronary disease, now its most common sequela. The effect of elevated blood pressure on cardiovascular disease morbidity and mortality in general and on coronary disease incidence in particular is independent of the influence of other predisposing atherogenic cofactors but is greatly affected by them. Elevated blood pressure is more often than usual associated with hyperlipidemia, hyperglycemia, hyperuricemia, excessive weight, elevated fibrinogen, and electrocardiogram (ECG) abnormalities, which enhance its impact. Hypertensive coronary candidates usually have an increased low-density lipoprotein/high-density lipoprotein (LDL/HDL) cholesterol ratio, impaired glucose tolerance. ECG abnormalities, or a cigarette smoking habit. These coexisting risk factors exert a greater influence than the character of the blood pressure elevation. Those at risk for hypertensive stroke have left ventricular hypertrophy (LVH), atrial fibrillation, cardiac failure, coronary disease, diabetes, or a cigarette habit. Cardiovascular risk ratios for hypertension diminish with advancing age, but this is offset by a higher absolute risk, making hypertension an important precursor of cardiovascular disease in the elderly.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7692148     DOI: 10.1097/00005344-199321002-00006

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  24 in total

Review 1.  Impact of dyslipidaemia. Lessons from clinical trials.

Authors:  W V Brown
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

2.  Impacts of components of the metabolic syndrome on health status and survival in an aged population.

Authors:  O Lindberg; R S Tilvis; T E Strandberg; J Valvanne; S Sairanen; C Ehnholm; J Tuomilehto
Journal:  Eur J Epidemiol       Date:  1997-06       Impact factor: 8.082

3.  Awareness, attitude, and distribution of high blood pressure among health professionals.

Authors:  Ahmed H Mitwalli; Ahmed Al Harthi; Hussam Mitwalli; Ayman Al Juwayed; Noura Al Turaif; Mohammed A Mitwalli
Journal:  J Saudi Heart Assoc       Date:  2012-11-24

4.  Association study of common variations of FBN1 gene and essential hypertension in Han Chinese population.

Authors:  Jinfeng Chen; Song Yang; Xianghai Zhao; Jiahui Shen; Hairu Wang; Yanchun Chen; Yanni Ji; Wen Wang; Wei Zhou; Xuecai Wang; Junming Tang; Xiangfeng Lu; Shufeng Chen; Laiyuan Wang; Hongfan Li; Chong Shen; Yanping Zhao
Journal:  Mol Biol Rep       Date:  2014-01-12       Impact factor: 2.316

5.  A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension.

Authors:  P Chan; B Tomlinson; Y J Chen; J C Liu; M H Hsieh; J T Cheng
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

6.  Added sugars in the diet are positively associated with diastolic blood pressure and triglycerides in children.

Authors:  Kenneth P Kell; Michelle I Cardel; Michelle M Bohan Brown; José R Fernández
Journal:  Am J Clin Nutr       Date:  2014-04-09       Impact factor: 7.045

7.  Uric acid levels predict future blood pressure and new onset hypertension in the general Japanese population.

Authors:  H Takase; G Kimura; Y Dohi
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

Review 8.  Goals of antihypertensive therapy.

Authors:  G E McVeigh; J Flack; R Grimm
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

9.  Association between hypertension and fragility fracture: a longitudinal study.

Authors:  S Yang; N D Nguyen; J R Center; J A Eisman; T V Nguyen
Journal:  Osteoporos Int       Date:  2013-07-27       Impact factor: 4.507

10.  Sleep heart rate variability assists the automatic prediction of long-term cardiovascular outcomes.

Authors:  Lulu Zhang; Huili Wu; Xiangyu Zhang; Xinfa Wei; Fengzhen Hou; Yan Ma
Journal:  Sleep Med       Date:  2019-12-16       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.